![The effect of nintedanib on lung functions and survival in idiopathic pulmonary fibrosis: real-life analysis of the Czech EMPIRE registry | BMC Pulmonary Medicine | Full Text The effect of nintedanib on lung functions and survival in idiopathic pulmonary fibrosis: real-life analysis of the Czech EMPIRE registry | BMC Pulmonary Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12890-023-02450-3/MediaObjects/12890_2023_2450_Fig1_HTML.png)
The effect of nintedanib on lung functions and survival in idiopathic pulmonary fibrosis: real-life analysis of the Czech EMPIRE registry | BMC Pulmonary Medicine | Full Text
![The effect of nintedanib on lung functions and survival in idiopathic pulmonary fibrosis: real-life analysis of the Czech EMPIRE registry | BMC Pulmonary Medicine | Full Text The effect of nintedanib on lung functions and survival in idiopathic pulmonary fibrosis: real-life analysis of the Czech EMPIRE registry | BMC Pulmonary Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12890-023-02450-3/MediaObjects/12890_2023_2450_Fig3_HTML.png)
The effect of nintedanib on lung functions and survival in idiopathic pulmonary fibrosis: real-life analysis of the Czech EMPIRE registry | BMC Pulmonary Medicine | Full Text
![Cancers | Free Full-Text | Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390 Cancers | Free Full-Text | Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390](https://www.mdpi.com/cancers/cancers-12-00808/article_deploy/html/images/cancers-12-00808-g001.png)
Cancers | Free Full-Text | Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390
![PDF) Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: Data from a national registry PDF) Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: Data from a national registry](https://i1.rgstatic.net/publication/321988624_Utilization_and_efficacy_of_second-line_targeted_therapy_in_metastatic_renal_cell_carcinoma_Data_from_a_national_registry/links/5a3c6fb3a6fdcc21d878031f/largepreview.png)